Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAB Foods Regulatory News (ABF)

Share Price Information for AB Foods (ABF)

Share Price is delayed by 15 minutes
Get Live Data
1,863.00    -1.00 (-0.05%)
Bid:
1,865.50
Ask:
1,866.50
Spread: 1.00 (0.054%)
Market Cap: £13.04b
ABF Live PriceLast checked at - London Stock Exchange

Intraday AB Foods Share Chart

Share Repurchase Programme

9 Nov 2022 07:00

RNS Number : 8069F
Associated British Foods PLC
09 November 2022
 

Associated British Foods plc

9 November 2022

 

Associated British Foods plc share repurchase programme

 

Further to its announcement on 8 November 2022, Associated British Foods plc (the "Company") announces that it is to commence the first tranche of its up to £500 million share buyback programme (the "Programme").

 

The first tranche of the Programme will be in the sum of up to £250 million and will commence today, 9 November 2022, and it is anticipated to end on or before 28 April 2023 (the "Engagement Period").

 

To execute the first tranche of this buyback, the Company has entered into an irrevocable and non-discretionary arrangement with Barclays Capital Securities Limited ("Barclays") to buy back up to £250 million of its ordinary shares (the "Engagement").

 

Under this arrangement, Barclays will act as principal and will make decisions independently from the Company under the Engagement. Barclays will carry out the arrangement through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. Purchases may continue during any closed period to which the Company is subject during the Engagement Period.

 

The sole purpose of the share buyback is to reduce the capital of the Company. All ordinary shares repurchased as part of this arrangement will be cancelled.

 

Share purchases will take place in open market transactions and be carried out on the London Stock Exchange and/or other recognised investment exchange(s) and may be made from time to time depending on market conditions, share price, trading volume and other factors.

 

Any purchases of ordinary shares by the Company in relation to this announcement will be effected within certain pre-set parameters and in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase ordinary shares granted by its shareholders (at the AGM in 2021, shareholders gave the Company authority to purchase a maximum of 79,167,418 ordinary shares), the Market Abuse Regulation 596/2014 (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018) and Chapter 12 of the Financial Conduct Authority's Listing Rules.

 

The Company intends to enter into arrangements to commence a second tranche of the Programme in the sum of £250 million in due course.

 

 

Further enquiries:

+44 (0)20 7399 6545

John Bason, Finance Director

Chris Barrie, Corporate Affairs Director

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKLBBLFLEFBB
Date   Source Headline
12th Nov 20245:59 pmRNSTransaction in Own Shares
11th Nov 20245:41 pmRNSTransaction in Own Shares
8th Nov 20245:39 pmRNSTransaction in Own Shares
7th Nov 20245:40 pmRNSTransaction in Own Shares
7th Nov 20249:35 amRNSDirector/PDMR Shareholding
6th Nov 20245:46 pmRNSTransaction in Own Shares
6th Nov 20247:00 amRNSShare repurchase programme
5th Nov 202410:57 amRNSARA 2024 and associated documents
5th Nov 20247:00 amRNSFinal and special dividend
5th Nov 20247:00 amRNSAnnual Results
1st Nov 20246:14 pmRNSTransaction in Own Shares
31st Oct 20244:52 pmRNSTotal Voting Rights
30th Oct 20245:39 pmRNSTransaction in Own Shares
28th Oct 20245:30 pmRNSTransaction in Own Shares
25th Oct 20245:35 pmRNSTransaction in Own Shares
24th Oct 20245:44 pmRNSTransaction in Own Shares
23rd Oct 20245:39 pmRNSTransaction in Own Shares
22nd Oct 20245:50 pmRNSTransaction in Own Shares
21st Oct 20245:37 pmRNSTransaction in Own Shares
18th Oct 20245:48 pmRNSTransaction in Own Shares
17th Oct 20245:51 pmRNSTransaction in Own Shares
16th Oct 20245:39 pmRNSTransaction in Own Shares
15th Oct 20245:44 pmRNSTransaction in Own Shares
14th Oct 20245:34 pmRNSTransaction in Own Shares
11th Oct 20245:44 pmRNSTransaction in Own Shares
10th Oct 20245:40 pmRNSTransaction in Own Shares
9th Oct 20245:37 pmRNSTransaction in Own Shares
8th Oct 20245:49 pmRNSTransaction in Own Shares
7th Oct 20245:57 pmRNSTransaction in Own Shares
4th Oct 20245:36 pmRNSTransaction in Own Shares
2nd Oct 20246:22 pmRNSTransaction in Own Shares- Replacement
2nd Oct 20245:46 pmRNSTransaction in Own Shares
1st Oct 20246:18 pmRNSTransaction in Own Shares
30th Sep 20244:39 pmRNSTotal Voting Rights
27th Sep 20245:53 pmRNSTransaction in Own Shares
26th Sep 20245:54 pmRNSTransaction in Own Shares
23rd Sep 20245:38 pmRNSTransaction in Own Shares
20th Sep 20245:59 pmRNSTransaction in Own Shares
19th Sep 20246:07 pmRNSTransaction in Own Shares
18th Sep 20245:33 pmRNSTransaction in Own Shares
17th Sep 20245:52 pmRNSTransaction in Own Shares
16th Sep 20245:47 pmRNSTransaction in Own Shares
13th Sep 20245:39 pmRNSTransaction in Own Shares
12th Sep 20245:42 pmRNSTransaction in Own Shares
11th Sep 20246:02 pmRNSTransaction in Own Shares
11th Sep 20247:00 amRNSExtension of Share Repurchase Programme
5th Sep 20247:00 amRNSDirectorate Change
5th Sep 20247:00 amRNSTrading Update
30th Aug 20245:20 pmRNSTotal Voting Rights
12th Aug 20246:05 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.